Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Argus Health
Express Scripts
Federal Trade Commission

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205473

« Back to Dashboard

NDA 205473 describes ETHACRYNATE SODIUM, which is a drug marketed by Mylan Institutional and Par Sterile Products and is included in two NDAs. It is available from two suppliers. Additional details are available on the ETHACRYNATE SODIUM profile page.

The generic ingredient in ETHACRYNATE SODIUM is ethacrynate sodium. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the ethacrynate sodium profile page.

Summary for 205473

Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 205473

Suppliers and Packaging for NDA: 205473

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ETHACRYNATE SODIUM ethacrynate sodium INJECTABLE;INJECTION 205473 ANDA Par Pharmaceutical, Inc. 42023-157 42023-157-89 1 VIAL in 1 CARTON (42023-157-89) > 50 mL in 1 VIAL
ETHACRYNATE SODIUM ethacrynate sodium INJECTABLE;INJECTION 205473 ANDA Par Pharmaceutical, Inc. 42023-157 42023-157-01 1 VIAL in 1 CARTON (42023-157-01) > 50 mL in 1 VIAL

Summary for product number 001

Approval Date:Jul 29, 2015TE:APRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Queensland Health
Johnson and Johnson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: